RHEB GTPase is over expressed in several prostate cancer cell lines and transgenic mice over-expressing Rheb specifically within the prostate epithelium develop low-grade prostatic intraepithelial neoplasia lesions by 10 months of age, accompanied with increased mTORC1 activity [175]. This evidence concerns the gene RHEB and prostate carcinoma.